{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:38:40Z","timestamp":1765438720234,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bmcl.2021.128372","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T02:49:04Z","timestamp":1632106144000},"page":"128372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Novel naphthyl based 1,2,4-trioxanes: Synthesis and in vivo efficacy in the Plasmodium yoelii nigeriensis in Swiss mice"],"prefix":"10.1016","volume":"51","author":[{"given":"Manvika","family":"Karnatak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hassam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murugesan","family":"Vanangamudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Kumar Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ved","family":"Prakash Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128372_b0005","unstructured":"WHO. World malaria report 2019. https:\/\/www.who.int\/ publications\/i\/item\/world-malaria-report-2019 (accessed March 1, 2020)."},{"key":"10.1016\/j.bmcl.2021.128372_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/fmc.10.274","article-title":"New hope in the fight against malaria?","volume":"3","author":"Rodrigues","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"Pink","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2021.128372_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00324","article-title":"Cytokines and chemokines in cerebral malaria pathogenesis","volume":"7","author":"Dunst","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmcl.2021.128372_b0025","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1021\/bi972233h","article-title":"Crystal structure of fructose-1,6-bisphosphate aldolase from the human malaria parasite Plasmodium falciparum","volume":"37","author":"Kim","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2021.128372_b0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(19)31097-9","article-title":"Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000\u201317: a spatial and temporal modelling study","volume":"394","author":"Weiss","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2021.128372_b0035","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ml100083c","article-title":"Evaluation of diarylureas for activity against Plasmodium falciparum","volume":"1","author":"Zhang","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","article-title":"Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000\u201317: a spatial and temporal modelling study","volume":"394","author":"Battle","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2021.128372_b0045","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1242\/jeb.00589","article-title":"Antimalarial drug discovery: old and new approaches","volume":"206","author":"Rosenthal","year":"2003","journal-title":"J Exp Biol"},{"key":"10.1016\/j.bmcl.2021.128372_b0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2021.128372_b0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in Plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmcl.2021.128372_b0060","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2012.02.021","article-title":"Outwitting evolution: fighting drug-resistant TB, malaria, and HIV","volume":"148","author":"Goldberg","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2021.128372_b0065","series-title":"Antimalarial chemotherapy","first-page":"15e25","article-title":"The history of antimalarial drugs","author":"Meshnick","year":"2001"},{"key":"10.1016\/j.bmcl.2021.128372_b0070","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1021\/jm200302d","article-title":"A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity","volume":"54","author":"Hussain","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2583.2000.00214.x","article-title":"Genetic mapping of two loci affecting DDT resistance in the malaria vector Anopheles gambiae","volume":"9","author":"Ranson","year":"2000","journal-title":"Insect Mol Biol"},{"key":"10.1016\/j.bmcl.2021.128372_b0080","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","article-title":"Malaria: progress, perils, and prospects for eradication","volume":"118","author":"Greenwood","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2021.128372_b0085","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(06)68900-9","article-title":"Artemisinin combination therapies","volume":"367","author":"Duffy","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2021.128372_b0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(10)70079-7","article-title":"Artemisinin combination therapy for vivax malaria","volume":"10","author":"Douglas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2021.128372_b0095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.meegid.2007.03.005","article-title":"Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa","volume":"7","author":"Holmgren","year":"2007","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.bmcl.2021.128372_b0100","first-page":"CD007483","article-title":"Artemisinin-based combination therapy for treating uncomplicated malaria","volume":"3","author":"Sinclair","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bmcl.2021.128372_b0105","first-page":"CD010927","article-title":"Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria","volume":"1","author":"Zani","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bmcl.2021.128372_b0110","unstructured":"China Cooperative Research Group on Qinghaosu and its derivatives as antimalarials. The Chemistry and synthesis of qinghaosu derivatives. J Tradit Chin Med. 1982;2:9e16."},{"key":"10.1016\/j.bmcl.2021.128372_b0115","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2021.128372_b0120","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm030571c","article-title":"A medicinal chemistry perspective on artemisinin and related endoperoxides","volume":"47","author":"O'Neill","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.drudis.2007.04.009","article-title":"New development in synthetic peroxidic drugs as artemisinin mimics","volume":"12","author":"Jefford","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2021.128372_b0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of antimalarial and anti-cancer agents","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmcl.2021.128372_b0135","first-page":"1","article-title":"Significance of winning the 2015 noble prize in physiology or medicine","volume":"6","author":"Liu","year":"2009","journal-title":"Cardovasc Diagn Ther"},{"key":"10.1016\/j.bmcl.2021.128372_b0140","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2021.128372_b0150","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/jo01363a042","article-title":"Tungstic acid catalyzed hydroxylation of cyclohexene in nonaqueous media","volume":"22","author":"Payne","year":"1957","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0155","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1021\/ja00359a027","article-title":"Reaction of bicyclic endoperoxides with carbonyl compounds. A new approach to 1,2,4-trioxanes","volume":"105","author":"Jefford","year":"1983","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2021.128372_b0160","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jm00399a004","article-title":"1,2,4-Trioxanes as potential antimalarial agents","volume":"31","author":"Kepler","year":"1988","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0165","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0040-4039(00)98789-6","article-title":"Synthesis of (+)-8a,9-secoartemisinin and related analogues","volume":"31","author":"Avery","year":"1990","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0170","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1021\/ja00021a053","article-title":"Cationic ring expansion of an ozonide to a 1,2,4-trioxane","volume":"113","author":"Bunnelle","year":"1991","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2021.128372_b0175","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/S0040-4039(00)92136-1","article-title":"Olefin oxidative cleavage and dioxetane formation using triethylsilyl hydrotrioxide: applications to preparation of potential antimalarial 1,2,4-trioxanes","volume":"32","author":"Posner","year":"1991","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0180","first-page":"948","article-title":"Synthesis of 1,2,4-trioxanes via intramolecular oxymercuration","volume":"947","author":"Bloodworth","year":"1991","journal-title":"J Chem Soc Chem Commun"},{"key":"10.1016\/j.bmcl.2021.128372_b0185","first-page":"8057","article-title":"6-Hydroxymethyl-1,2,4-trioxanes and derivatives: an alternative 1,2,4-trioxane synthesis from \u03b2\u2032\u03b3\u2032-unsaturated \u03b2-hydroxyhydroperoxides","volume":"35","author":"Bloodwarth","year":"1994","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0190","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1016\/S0040-4039(01)00791-2","article-title":"Regioselective Mukaiyama hydroperoxysilylation of 2-alkyl-or 2-aryl-prop-2-en-1-ols: application to a new synthesis of 1,2,4-trioxanes","volume":"42","author":"O'Neill","year":"2001","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0195","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1021\/ol0492142","article-title":"Application of thiol-olefin co-oxygenation methodology to a new synthesis of the 1,2,4-trioxane pharmacophore","volume":"6","author":"O'Neill","year":"2004","journal-title":"Org Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0200","first-page":"2433","article-title":"A family of new 1,2,4-trioxanes by photooxygenation of allylic alcohols in sensitizer-doped polymers and secondary reactions","author":"Bartoschek","year":"2005","journal-title":"Synthesis"},{"key":"10.1016\/j.bmcl.2021.128372_b0205","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1002\/anie.200701397","article-title":"Bicyclic peroxides and perorthoester with 1,2,4-trioxane structures","volume":"46","author":"Griesbeck","year":"2007","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2021.128372_b0210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1021\/ol8022853","article-title":"Preparation of bicyclic 1,2,4-trioxanes from \u03b3, \u03b4-unsaturated ketones","volume":"11","author":"Ramirez","year":"2009","journal-title":"Org Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0215","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1021\/jm9002523","article-title":"Antimalarial peroxide dyads from natural artemisinin and hydroxyalkylated 1,2,4-trioxanes","volume":"52","author":"Griesbeck","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0220","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1016\/S0040-4039(00)97202-2","article-title":"Preparation of \u03b2-hydroxyhydroperoxides by photooxygenation of allylic alcohols and their elaboration into 1,2,4-trioxanes","volume":"31","author":"Singh","year":"1990","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0225","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1021\/jm801006v","article-title":"Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice","volume":"51","author":"Singh","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0230","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/0960-894X(95)00322-K","article-title":"In vivo potent antimalarial 1,2,4-trioxanes: synthesis and activity of 8-(R-arylvinyl)-6,7,10-trioxaspiro[4,5]decanes and 3-(R-arylvinyl)-1,2,5-trioxaspiro[5,5]undecanes against Plasmodium berghei in mice","volume":"5","author":"Singh","year":"1995","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0235","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1016\/S0960-894X(03)00782-0","article-title":"Geraniol-derived 1,2,4-trioxanes with potent in vivo antimalarial activity","volume":"13","author":"Singh","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0240","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1021\/jm100678p","article-title":"Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes","volume":"53","author":"Singh","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128372_b0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bmcl.2003.10.051","article-title":"Orally active amino functionalized antimalarial 1,2,4-trioxanes","volume":"14","author":"Singh","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0250","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1016\/j.bmcl.2005.07.013","article-title":"New orally active spiro 1,2,4-trioxanes with high antimalarial potency","volume":"15","author":"Singh","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0255","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1016\/j.bmcl.2010.06.045","article-title":"6-(4-Aryloxy-phenyl)vinyl-1,2,4-trioxanes: a new series of orally active peroxides effective against multidrug-resistant Plasmodium yoelii in Swiss mice","volume":"20","author":"Singh","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0260","doi-asserted-by":"crossref","first-page":"128305","DOI":"10.1016\/j.bmcl.2021.128305","article-title":"Synthesis of novel 1,2,4-trioxanes and antimalarial evaluation against multidrug-resistant Plasmodium yoelii nigeriensis","volume":"49","author":"Shukla","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128372_b0265","unstructured":"(a) Peters W. Techniques for the study of drug response in experimental malaria. In Chemotherapy and drug resistance in malaria; Academic Press: London, 1970; 64-136. (b) In vivo test procedure: The colony bred Swiss mice (25 \u00b1 1g) were inoculated with 1X106 parasitized RBC on day zero and treatment was administered to a group of five mice at each dose, from day 0 to 3, in two divided doses daily. The drug dilutions of compounds 9a1-a4, 9b1-b4, 10-13 and 9c1-c4 were prepared in groundnut oil so as to contain the required amount of the drug (1.2 mg for a dose of 96 mg\/kg, 0.6 mg for a dose of 48 mg\/kg and 0.3 mg for a dose of 24 mg\/kg) in 0.1 mL and administered orally\/intramuscularly for each dose. Parasitaemia level were recorded from thin blood smears between day 4-28. The animals which did not develop patent infection till day 28 were recorded as cured."},{"key":"10.1016\/j.bmcl.2021.128372_b0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/expr.1999.4465","article-title":"Azithromycin: antimalarial profile against blood and sporozoite-induced infections in mice and monkeys","volume":"94","author":"Puri","year":"2000","journal-title":"Expl Parasitol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21005990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21005990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:42:03Z","timestamp":1760773323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21005990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":54,"alternative-id":["S0960894X21005990"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128372","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel naphthyl based 1,2,4-trioxanes: Synthesis and in vivo efficacy in the Plasmodium yoelii nigeriensis in Swiss mice","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128372"}}